Michael J. Fox Foundation
Erisyon Wins $189K Michael J. Fox Foundation Grant for Protein Biomarker Discovery
Erisyon will use its single-molecule protein sequencing technology to detect and validate biomarkers for early detection of Parkinson's disease.
The Michael J. Fox Foundation-led project aims to lead researchers to new insights about biomarkers indicating Parkinson's disease progression.
NIH Launches Parkinson's Disease Research Partnership
The partnership includes biopharmaceutical, life science, and non-profit organizations, as well as several US government agencies.
Michael J. Fox Foundation Grants $4M to 23andMe for New Parkinson's Disease Collaboration
The study will provide researchers, drugmakers, regulators, and payors with insight into the genetics of the disease and experience of the patients.
Using data from the Parkinson's Progression Markers Initiative, GNS Healthcare identifies genetic and molecular markers of rapid motor progression.